Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.699
5.86 %
$ 20.1 M
Market Cap
-0.85
P/E
Price Target
Average
35.91%
Revenue Forecast
Estimate
203.71%
EBIT
Estimate
--46.19%
Net Income
Estimate
26.51%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cyclo Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for CYTH of $0.95 , with forecasts ranging from a low of $0.95 to a high of $0.95 .
CYTH Lowest Price Target
Wall Street Target
0.95 USD
35.91%
CYTH Average Price Target
Wall Street Target
0.95 USD
35.91%
CYTH Highest Price Target
Wall Street Target
0.95 USD
35.91%
REVENUE FORECAST
Revenue Forecast Chart CYTH
EBIT FORECAST
EBIT Forecast Chart CYTH
NET INCOME FORECAST
Net Income Chart CYTH